Henderson, NV, United States
Henderson, NV, United States

Time filter

Source Type

This report assesses future trends in molecular imaging equipment revenues as well as growth in the number of unit shipments over the next few years. This will provide value to market participants that design and manufacture molecular imaging equipment. Market participants will also be provided insights on recent industry and technology trends that are shaping the molecular imaging market. Radiopharmaceutical manufacturers will be provided with key insights on the evolving usage trends of workhorse FDG and Tc-99m radiopharmaceuticals and the increasing adoption of new radiopharmaceuticals across new clinical areas. Companies that are in the process of developing software to improve quantitation accuracy, lower dosages, and reduce scan times for both PET and SPECT will be provided with key insights on how the molecular imaging market is growing as well as the factors that are required to facilitate greater adoption of PET and SPECT technologies. Key Topics Covered: 1. Research Methodology 2. Executive Summary-Molecular Imaging 3. Executive Summary-Radiopharmaceuticals 9. Key Products and Participants 10. Latest Trends Among the Big Three Competitors-Philips Healthcare 11. GE Healthcare 12. Siemens Healthineers 13. Companies to Look Out For 14. Other Issues Impacting Growth Of Molecular Imaging 15. Key Technology and Industry Trends 16. Drivers and Restraints-Total Radiopharmaceuticals Market 17. PET Radiopharmaceuticals Segment 18. SPECT Radiopharmaceuticals Segment 19. Key Products and Participants 20. Key Companies to Look Out For 21. Key Industry Trends 22. Role of New Radiopharmaceuticals in Oncology 23. The Last Word 24. Appendix 25. Medicare Hospital Outpatient Prospective Payment System (HOPPS) Companies Mentioned - Advanced Accelerator Applications - Bio-Nucleonics - Blue Earth - Bracco - Cardinal - Eckert & Ziegler Nuclitec - Eli Lilly - GE - IBA Molecular - Jubilant Draximage - Kimberley-clark - Lantheus - MDS Nordion - Mallinckrodt - Mayo Clinic - Molecular Dynamics - Navidea - NeuSoft - PETNET - Pharmalucence - Philips - Piramal - Siemens Healthineers - Spectrum - Toshiba - UltraSPECT For more information about this report visit http://www.researchandmarkets.com/research/5mxv25/analysis_of_the Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/united-states-molecular-imaging-equipment-and-radiopharmaceuticals-market-2017-2023---research-and-markets-300440832.html


The present invention provides a process to clean water filtration media in a filtration bed. The process includes applying a granular cleaner to the water filtration media and applying an activator to the water filtration media. This causes a chemical reaction between the granular cleaner, activator and water filtration media resulting in the cleaning of the water filtration media. The residual granular cleaner and activator, along with suspended and dissolved contamination from the water filtration media, are removed by rinsing with water.


The present invention provides a process to clean water filtration media in a filtration bed. The process includes applying a granular cleaner to the water filtration media and applying an activator to the water filtration media. This causes a chemical reaction between the granular cleaner, activator and water filtration media resulting in the cleaning of the water filtration media. The residual granular cleaner and activator, along with suspended and dissolved contamination from the water filtration media, are removed by rinsing with water.


A stabilized mixed oxidant solution may be produced by flowing a starting solution (e.g., salt brine, hypochlorous acid, and/or sodium hypochlorite) through a flow-through electrochemical module including first and second passages separated by an ion permeable membrane while electric power is applied between an anode and cathode in electrical communication with the first and second passages, respectively. An initially acidic anolyte solution received from the first (anode) passage is stabilized by elevating pH to yield a stabilized mixed oxidant solution. Methods of using the mixed oxidant solution are further provided.


The present invention relates to a process for removing surface contaminants from water filtration media contained in a water filtration bed including granular activated carbon (GAC). This process comprises the steps of:applying a cleaner in granular form onto said water filtration media, while the filtration media is located within the filtration bed;applying an active oxygen donor in liquid form to said water filtration bed, to initiate at least one chemical reaction between the cleaner, the active oxygen donor, and the surface contaminants on the water filtration media, causing at least one of suspension and dissolution of contaminants received from the water filtration media;after initiating of said at least one chemical reaction, rinsing the filtration media in the water filtration bed with water for removing any of residual cleaner, residual active oxygen donor, suspended contaminants, and dissolved contaminants from the water filtration media.


A stabilized mixed oxidant solution may be produced by flowing a starting solution (e.g., salt brine, hypochlorous acid, and/or sodium hypochlorite) through a flow-through electrochemical module including first and second passages separated by an ion permeable membrane while electric power is applied between an anode and cathode in electrical communication with the first and second passages, respectively. An initially acidic anolyte solution received from the first (anode) passage is stabilized by elevating pH to yield a stabilized mixed oxidant solution. Methods of using the mixed oxidant solution are further provided.


Compositions and methods for removing surface deposits in situ from filtration media contained in water filtration beds may include a solid acid component, a solid oxidizer, low temperature activator, a dessicant, an anti-caking agent, a pH indicator, a corrosion inhibitor, a surfactant, a chelating agent, and/or a defoaming agent. A granular acid component may include sodium bisulfate, and a granular oxidizing component may include at least one of sodium percarbonate, sodium perborate, potassium percarbonate, and potassium perborate. Compositions may be applied to top surface and/or subsurface regions of a filter bed, in wetted or dry form. A kit includes a container with dry composition and instructions or indicia for cleaning water filtration media using the composition.


Methods and compositions for improving water quality by reducing chlorine demand, decreasing disinfection by-products and controlling deposits in water systems include adding low concentrations of supplemental oxidants, for example, RE-Ox to the systems.


Methods and compositions for improving water quality by reducing chlorine demand, decreasing disinfection by-products and controlling deposits in drinking water distribution systems include adding low concentrations of supplemental oxidants, for example, RE-Ox to the systems.


Methods and compositions for improving water quality by reducing chlorine demand, decreasing disinfection by-products and controlling deposits in water systems include adding low concentrations of supplemental oxidants, for example, RE-Ox to the systems.

Loading Blue Earth collaborators
Loading Blue Earth collaborators